The most-studied VO2 max interval protocol
You can change this. Whether this specific protocol cuts death is untested — no trial has tested it against an all-cause mortality endpoint.
Four 4-minute bouts at 90–95% of max heart rate, separated by 3-minute active recoveries.
Dose
4 × 4 min at 90–95% HRmax, with 3 min active recovery at 60–70% HRmax. 1–2 sessions per week.
Dose-response shape: plateau
How to get there
Four 4-minute intervals at 90–95% HRmax with 3-minute active recoveries, 1–2 times a week. The intensity is the hard part — most people self-selecting it land below 90%.
Heart rate through the session against 90–95% HRmax; VO2 max retested periodically to see whether the stimulus is landing.
Generation 100 found no significant all-cause mortality difference between high-intensity intervals, moderate training, and control over five years — more intensity is not shown to buy more life.
Evidence, by endpoint
| Endpoint | Grade | Citation |
|---|---|---|
| VO2 max | A | Helgerud et al. 2007, Med Sci Sports Exerc Aerobic high-intensity intervals improved VO2 max more than moderate continuous training. |
| Cardiac remodeling in heart failure | A | Wisløff et al. 2007, Circulation Improved VO2 max and reversed left ventricular remodeling in heart failure patients. |
| All-cause mortality | X | No trial has tested this protocol against an all-cause mortality endpoint. |
What the protocol is
Four 4-minute intervals at 90–95% of max heart rate, each followed by 3 minutes of active recovery at 60–70% HRmax, run 1–2 times per week. It is one of the most-studied VO2 max protocols in the exercise-physiology literature (Helgerud et al. 2007, Med Sci Sports Exerc) and has also been tested in heart failure patients, where it improved VO2 max and reversed left ventricular remodeling (Wisløff et al. 2007, Circulation).
What the evidence does not cover
No trial has tested this specific protocol against an all-cause mortality endpoint. Generation 100 (Stensvold et al. 2020, BMJ) randomized 1,567 adults aged 70–77 to high-intensity intervals, moderate training, or control over five years and found no significant difference in all-cause mortality between groups — a larger, longer, mortality-endpoint trial that did not find the effect this protocol is often assumed to produce.
Where it has been overstated
SMARTEX-HF (Ellingsen et al. 2017, Circulation) found 4×4 interval training did not outperform moderate continuous training in heart failure patients, and adherence to the prescribed intensity was poor — the same 90–95% HRmax difficulty most people run into outside a trial setting.
What argues against this
SMARTEX-HF (Ellingsen et al. 2017, Circulation) found 4×4 interval training did NOT outperform moderate continuous training in heart failure patients, and adherence to the prescribed intensity was poor. The protocol is oversold relative to that result.
Gotchas
- The adaptation is eccentric remodeling — increased left ventricular end-diastolic volume — not hypertrophy in the pathological sense. The unqualified word ‘hypertrophy’ reads as disease.
- 90–95% HRmax is genuinely hard. Most people self-selecting this intensity land below it, which is the same adherence problem SMARTEX-HF measured.
Safety
- Screen before prescribing high-intensity work to untrained, older, or cardiac-history individuals.
Educational content only — not medical advice, diagnosis, or treatment. Not a medical device; not FDA evaluated. Consult a qualified healthcare professional about your own health, and call emergency services for urgent symptoms. Full medical disclaimer →